Net Income - MedCap AB (publ) (STO:MCAP) - Alpha Spread

MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 493 SEK 2.6% Market Closed
Market Cap: 7.4B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Net Income Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Net Income
kr282m
CAGR 3-Years
41%
CAGR 5-Years
32%
CAGR 10-Years
54%
AddLife AB
STO:ALIF B
Net Income
kr339m
CAGR 3-Years
-20%
CAGR 5-Years
16%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Net Income
-kr1.7B
CAGR 3-Years
-214%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Net Income
kr313m
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
20%
G
Genovis AB
STO:GENO
Net Income
kr23.2m
CAGR 3-Years
41%
CAGR 5-Years
38%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Net Income
kr15.1m
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Net Income?
Net Income
282m SEK

Based on the financial report for Jun 30, 2024, MedCap AB (publ)'s Net Income amounts to 282m SEK.

What is MedCap AB (publ)'s Net Income growth rate?
Net Income CAGR 10Y
54%

Over the last year, the Net Income growth was 45%. The average annual Net Income growth rates for MedCap AB (publ) have been 41% over the past three years , 32% over the past five years , and 54% over the past ten years .

Back to Top